Karius Inc. Adds Dr. Norman Sharpless, Former National Cancer Institute Head, and Elizabeth O'Farrell, Eli Lilly Veteran, to its Board of Directors
Sharpless, highly regarded for his contributions to healthcare leadership and patient-centric innovation, served as the Director of the National Cancer Institute (NCI) from 2017 to 2022.
- Sharpless, highly regarded for his contributions to healthcare leadership and patient-centric innovation, served as the Director of the National Cancer Institute (NCI) from 2017 to 2022.
- In 2019, Sharpless served as the U.S. Food and Drug Administration's (FDA) Acting Commissioner for seven months.
- Former Eli Lilly executive, O'Farrell, joins the Board with more than two decades of global responsibility within a multinational public company.
- "I'm very excited to have the opportunity to join the Karius Board of Directors at such an exciting time for the company," O'Farrell said.